Insights into Release of Interleukin-1β from Platelets

Thromb Haemost 2022; 122(04): 475
DOI: 10.1055/a-1683-8567

Invited T&H Insights

Tobias Geisler

¹Department of Cardiology and Angiology, Eberhard Karls University Tübingen Faculty of Medicine, Tubingen, Baden-Württemberg, Germany

References
1 Ridker PM, Everett BM, Thuren T. et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377 (12) 1119-1131
2 Beaulieu LM, Lin E, Mick E. et al. Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 2014; 34 (03) 552-564
3 Pennings GJ, Reddel CJ, Traini M. et al. Rapid release of interleukin-1β from human platelets is independent of NLRP3 and caspase. Thromb Haemost 2022; 122 (04) 517-528
4 Hettwer J, Hinterdobler J, Miritsch B. et al. Interleukin-1β suppression dampens inflammatory leukocyte production and uptake in atherosclerosis. Cardiovasc Res 2021;
5 Kimura H, Ishibashi T, Shikama Y. et al. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. Blood 1990; 76 (12) 2493-2500